NRIX · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2021-07-13 compared with 2021-04-13 · 2 added, 4 removed, 24 unchanged (20% of the section changed)
2 unchanged sentences
Filed or Furnished Herewith
−Removed: First Amendment to Collaboration and License Agreement, dated January 6, 2021, by and between the Registrant and Genzyme Corporation
−Removed: February 16, 2021
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
11 unchanged sentences
NURIX THERAPEUTICS, INC.
−Removed: April 13, 2021
+Added: July 13, 2021
/s/ Arthur T.
2 unchanged sentences
(Principal Executive Officer)
−Removed: April 13, 2021
+Added: July 13, 2021
/s/ Hans van Houte
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.